nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—ALB—membranous glomerulonephritis	0.862	1	CbGaD
Naproxen—AKR1C3—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—TBXAS1—membranous glomerulonephritis	0.0108	0.0966	CbGpPWpGaD
Naproxen—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—TBXAS1—membranous glomerulonephritis	0.00472	0.042	CbGpPWpGaD
Naproxen—AKR1C3—Retinoid metabolism and transport—LRP2—membranous glomerulonephritis	0.00409	0.0364	CbGpPWpGaD
Naproxen—AKR1C3—Arachidonic acid metabolism—TBXAS1—membranous glomerulonephritis	0.00391	0.0349	CbGpPWpGaD
Naproxen—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—TBXAS1—membranous glomerulonephritis	0.00374	0.0334	CbGpPWpGaD
Naproxen—PTGS1—Eicosanoid Synthesis—TBXAS1—membranous glomerulonephritis	0.00306	0.0273	CbGpPWpGaD
Naproxen—AKR1C3—nephron tubule—membranous glomerulonephritis	0.00285	0.13	CbGeAlD
Naproxen—SLC22A6—nephron tubule—membranous glomerulonephritis	0.00284	0.13	CbGeAlD
Naproxen—UGT2B7—kidney—membranous glomerulonephritis	0.00272	0.124	CbGeAlD
Naproxen—PTGS1—Prostaglandin Synthesis and Regulation—TBXAS1—membranous glomerulonephritis	0.00256	0.0229	CbGpPWpGaD
Naproxen—AKR1C3—cortex of kidney—membranous glomerulonephritis	0.00244	0.111	CbGeAlD
Naproxen—PTGS2—Eicosanoid Synthesis—TBXAS1—membranous glomerulonephritis	0.00243	0.0217	CbGpPWpGaD
Naproxen—SLC22A6—cortex of kidney—membranous glomerulonephritis	0.00243	0.111	CbGeAlD
Naproxen—UGT1A1—kidney—membranous glomerulonephritis	0.00231	0.105	CbGeAlD
Naproxen—SLCO1A2—Transport of organic anions—ALB—membranous glomerulonephritis	0.00222	0.0198	CbGpPWpGaD
Naproxen—AKR1C3—Diseases associated with visual transduction—LRP2—membranous glomerulonephritis	0.00209	0.0186	CbGpPWpGaD
Naproxen—PTGS2—Prostaglandin Synthesis and Regulation—TBXAS1—membranous glomerulonephritis	0.00203	0.0181	CbGpPWpGaD
Naproxen—AKR1C3—Retinoid metabolism and transport—APOE—membranous glomerulonephritis	0.00173	0.0154	CbGpPWpGaD
Naproxen—AKR1C3—Retinoid metabolism and transport—APOA1—membranous glomerulonephritis	0.00171	0.0153	CbGpPWpGaD
Naproxen—PTGS1—Arachidonic acid metabolism—TBXAS1—membranous glomerulonephritis	0.0017	0.0152	CbGpPWpGaD
Naproxen—SLCO1A2—Recycling of bile acids and salts—ALB—membranous glomerulonephritis	0.00165	0.0147	CbGpPWpGaD
Naproxen—ALB—HDL-mediated lipid transport—ABCA1—membranous glomerulonephritis	0.00165	0.0147	CbGpPWpGaD
Naproxen—SLCO1A2—kidney—membranous glomerulonephritis	0.00157	0.0714	CbGeAlD
Naproxen—AKR1C3—Bile acid and bile salt metabolism—ALB—membranous glomerulonephritis	0.00151	0.0134	CbGpPWpGaD
Naproxen—PTGS2—Arachidonic acid metabolism—TBXAS1—membranous glomerulonephritis	0.00135	0.0121	CbGpPWpGaD
Naproxen—Fenoprofen—ALB—membranous glomerulonephritis	0.00123	0.281	CrCbGaD
Naproxen—ALB—Scavenging of heme from plasma—APOA1—membranous glomerulonephritis	0.0012	0.0107	CbGpPWpGaD
Naproxen—PTGS1—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.00119	0.0106	CbGpPWpGaD
Naproxen—CYP2C8—Arachidonic acid metabolism—TBXAS1—membranous glomerulonephritis	0.0011	0.00981	CbGpPWpGaD
Naproxen—CYP2C8—kidney—membranous glomerulonephritis	0.00109	0.0499	CbGeAlD
Naproxen—ALB—HDL-mediated lipid transport—APOE—membranous glomerulonephritis	0.00108	0.00965	CbGpPWpGaD
Naproxen—ALB—HDL-mediated lipid transport—APOA1—membranous glomerulonephritis	0.00107	0.00954	CbGpPWpGaD
Naproxen—PTGS1—epithelium—membranous glomerulonephritis	0.000989	0.0451	CbGeAlD
Naproxen—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—membranous glomerulonephritis	0.00096	0.00856	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—LRP2—membranous glomerulonephritis	0.00096	0.00856	CbGpPWpGaD
Naproxen—UGT2B7—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.000957	0.00853	CbGpPWpGaD
Naproxen—CYP2C8—Cytochrome P450 - arranged by substrate type—TBXAS1—membranous glomerulonephritis	0.000951	0.00848	CbGpPWpGaD
Naproxen—ALB—Lipoprotein metabolism—ABCA1—membranous glomerulonephritis	0.000946	0.00843	CbGpPWpGaD
Naproxen—PTGS2—epithelium—membranous glomerulonephritis	0.000945	0.0431	CbGeAlD
Naproxen—Indomethacin—ALB—membranous glomerulonephritis	0.000905	0.207	CrCbGaD
Naproxen—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—membranous glomerulonephritis	0.000903	0.00805	CbGpPWpGaD
Naproxen—CYP2C9—Arachidonic acid metabolism—TBXAS1—membranous glomerulonephritis	0.000895	0.00798	CbGpPWpGaD
Naproxen—PTGS1—kidney—membranous glomerulonephritis	0.000887	0.0405	CbGeAlD
Naproxen—AKR1C3—Diseases associated with visual transduction—APOE—membranous glomerulonephritis	0.000885	0.00789	CbGpPWpGaD
Naproxen—AKR1C3—Diseases associated with visual transduction—APOA1—membranous glomerulonephritis	0.000875	0.0078	CbGpPWpGaD
Naproxen—SLCO1A2—Bile acid and bile salt metabolism—ALB—membranous glomerulonephritis	0.000862	0.00768	CbGpPWpGaD
Naproxen—PTGS2—kidney—membranous glomerulonephritis	0.000848	0.0387	CbGeAlD
Naproxen—PTGS2—S1P1 pathway—RHOA—membranous glomerulonephritis	0.000839	0.00748	CbGpPWpGaD
Naproxen—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—membranous glomerulonephritis	0.000825	0.00736	CbGpPWpGaD
Naproxen—Flurbiprofen—ALB—membranous glomerulonephritis	0.000801	0.183	CrCbGaD
Naproxen—UGT1A1—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.000778	0.00693	CbGpPWpGaD
Naproxen—CYP2C9—Cytochrome P450 - arranged by substrate type—TBXAS1—membranous glomerulonephritis	0.000774	0.0069	CbGpPWpGaD
Naproxen—CYP2C8—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.000771	0.00687	CbGpPWpGaD
Naproxen—CYP1A2—Arachidonic acid metabolism—TBXAS1—membranous glomerulonephritis	0.000765	0.00682	CbGpPWpGaD
Naproxen—Ketoprofen—ALB—membranous glomerulonephritis	0.000724	0.166	CrCbGaD
Naproxen—Ibuprofen—ALB—membranous glomerulonephritis	0.000713	0.163	CrCbGaD
Naproxen—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—membranous glomerulonephritis	0.0007	0.00624	CbGpPWpGaD
Naproxen—CYP1A2—Cytochrome P450 - arranged by substrate type—TBXAS1—membranous glomerulonephritis	0.000661	0.0059	CbGpPWpGaD
Naproxen—PTGS1—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.000634	0.00565	CbGpPWpGaD
Naproxen—ALB—Lipid and lipoprotein metabolism—ABCA1—membranous glomerulonephritis	0.000628	0.0056	CbGpPWpGaD
Naproxen—CYP2C9—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.000627	0.00559	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—ABCA1—membranous glomerulonephritis	0.000622	0.00555	CbGpPWpGaD
Naproxen—ALB—Lipoprotein metabolism—APOE—membranous glomerulonephritis	0.000622	0.00554	CbGpPWpGaD
Naproxen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—membranous glomerulonephritis	0.000621	0.00554	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—ABCA1—membranous glomerulonephritis	0.000618	0.00551	CbGpPWpGaD
Naproxen—ALB—Lipoprotein metabolism—APOA1—membranous glomerulonephritis	0.000615	0.00548	CbGpPWpGaD
Naproxen—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—membranous glomerulonephritis	0.000598	0.00533	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—PLG—membranous glomerulonephritis	0.000579	0.00516	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—PLG—membranous glomerulonephritis	0.000575	0.00513	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.000559	0.00499	CbGpPWpGaD
Naproxen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—membranous glomerulonephritis	0.000538	0.0048	CbGpPWpGaD
Naproxen—CYP1A2—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.000536	0.00478	CbGpPWpGaD
Naproxen—ALB—Platelet degranulation—SPARC—membranous glomerulonephritis	0.000529	0.00472	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—PTPRU—membranous glomerulonephritis	0.000523	0.00466	CbGpPWpGaD
Naproxen—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—membranous glomerulonephritis	0.000504	0.0045	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—ABCA1—membranous glomerulonephritis	0.000503	0.00449	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.000499	0.00444	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—ABCA1—membranous glomerulonephritis	0.000494	0.00441	CbGpPWpGaD
Naproxen—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—membranous glomerulonephritis	0.000484	0.00432	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.00048	0.00428	CbGpPWpGaD
Naproxen—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOA1—membranous glomerulonephritis	0.000479	0.00427	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—PLG—membranous glomerulonephritis	0.000468	0.00417	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—PLG—membranous glomerulonephritis	0.000459	0.0041	CbGpPWpGaD
Naproxen—ALB—FOXA2 and FOXA3 transcription factor networks—APOA1—membranous glomerulonephritis	0.000453	0.00403	CbGpPWpGaD
Naproxen—CYP1A2—Melatonin metabolism and effects—APOE—membranous glomerulonephritis	0.000447	0.00399	CbGpPWpGaD
Naproxen—ALB—Lipid and lipoprotein metabolism—APOE—membranous glomerulonephritis	0.000413	0.00368	CbGpPWpGaD
Naproxen—CYP2C8—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.00041	0.00365	CbGpPWpGaD
Naproxen—ALB—Lipid and lipoprotein metabolism—APOA1—membranous glomerulonephritis	0.000409	0.00364	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—APOE—membranous glomerulonephritis	0.000407	0.00363	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—APOA1—membranous glomerulonephritis	0.000405	0.00361	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—APOA1—membranous glomerulonephritis	0.000402	0.00359	CbGpPWpGaD
Naproxen—ALB—Platelet degranulation—PLG—membranous glomerulonephritis	0.000401	0.00358	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—ABCA1—membranous glomerulonephritis	0.0004	0.00356	CbGpPWpGaD
Naproxen—ALB—Response to elevated platelet cytosolic Ca2+—PLG—membranous glomerulonephritis	0.000382	0.00341	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—PLG—membranous glomerulonephritis	0.000372	0.00331	CbGpPWpGaD
Naproxen—CYP2C9—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.000333	0.00297	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—APOA1—membranous glomerulonephritis	0.000327	0.00292	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—APOA1—membranous glomerulonephritis	0.000321	0.00286	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	0.000321	0.00286	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—ALB—membranous glomerulonephritis	0.000321	0.00286	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.00032	0.00285	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.000285	0.00254	CbGpPWpGaD
Naproxen—CYP1A2—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.000285	0.00254	CbGpPWpGaD
Naproxen—ALB—Platelet degranulation—APOA1—membranous glomerulonephritis	0.000281	0.0025	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.000275	0.00245	CbGpPWpGaD
Naproxen—ALB—Response to elevated platelet cytosolic Ca2+—APOA1—membranous glomerulonephritis	0.000267	0.00238	CbGpPWpGaD
Naproxen—AKR1C3—Disease—LRP2—membranous glomerulonephritis	0.000265	0.00236	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—IL1B—membranous glomerulonephritis	0.000261	0.00233	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—APOA1—membranous glomerulonephritis	0.00026	0.00232	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—IL1B—membranous glomerulonephritis	0.000259	0.00231	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—ALB—membranous glomerulonephritis	0.000255	0.00227	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—TBXAS1—membranous glomerulonephritis	0.000249	0.00222	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.000243	0.00217	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—SPARC—membranous glomerulonephritis	0.000235	0.00209	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—LRP2—membranous glomerulonephritis	0.000222	0.00198	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.000217	0.00193	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000214	0.00191	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	0.000211	0.00188	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—IL1B—membranous glomerulonephritis	0.000211	0.00188	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	0.000209	0.00186	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.000209	0.00186	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—IL1B—membranous glomerulonephritis	0.000207	0.00185	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—membranous glomerulonephritis	0.000197	0.00176	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—RHOA—membranous glomerulonephritis	0.000195	0.00173	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.000193	0.00172	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—LRP2—membranous glomerulonephritis	0.000186	0.00166	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	0.000184	0.00164	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—PLG—membranous glomerulonephritis	0.000178	0.00159	CbGpPWpGaD
Naproxen—SLCO1A2—SLC-mediated transmembrane transport—ALB—membranous glomerulonephritis	0.000177	0.00158	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.000172	0.00154	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—IL1B—membranous glomerulonephritis	0.000168	0.00149	CbGpPWpGaD
Naproxen—SLC22A6—SLC-mediated transmembrane transport—ALB—membranous glomerulonephritis	0.000167	0.00148	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.000166	0.00148	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	0.000165	0.00148	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IL1B—membranous glomerulonephritis	0.000164	0.00146	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—TBXAS1—membranous glomerulonephritis	0.000164	0.00146	CbGpPWpGaD
Naproxen—SLCO1A2—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	0.000162	0.00145	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.000157	0.0014	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.000156	0.00139	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—MMP9—membranous glomerulonephritis	0.000154	0.00138	CbGpPWpGaD
Naproxen—SLC22A6—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	0.000153	0.00136	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—LRP2—membranous glomerulonephritis	0.000146	0.0013	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—ABCA1—membranous glomerulonephritis	0.000143	0.00128	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—TBXAS1—membranous glomerulonephritis	0.000143	0.00127	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PLA2G1B—membranous glomerulonephritis	0.00014	0.00125	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.00014	0.00125	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	0.00014	0.00125	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.000139	0.00124	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.000135	0.0012	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.000134	0.0012	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—TBXAS1—membranous glomerulonephritis	0.000133	0.00119	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.000128	0.00114	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—LRP2—membranous glomerulonephritis	0.000127	0.00113	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—APOA1—membranous glomerulonephritis	0.000124	0.00111	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000122	0.00109	CbGpPWpGaD
Naproxen—ALB—Hemostasis—SPARC—membranous glomerulonephritis	0.000121	0.00108	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	0.000121	0.00108	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	0.00012	0.00107	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—LRP2—membranous glomerulonephritis	0.000119	0.00106	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000114	0.00102	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.000114	0.00102	CbGpPWpGaD
Naproxen—SLCO1A2—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	0.000114	0.00101	CbGpPWpGaD
Naproxen—AKR1C3—Disease—APOE—membranous glomerulonephritis	0.000112	0.001	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—PLG—membranous glomerulonephritis	0.000111	0.000991	CbGpPWpGaD
Naproxen—AKR1C3—Disease—APOA1—membranous glomerulonephritis	0.000111	0.00099	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	0.000111	0.00099	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.00011	0.000979	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.000109	0.000975	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—TBXAS1—membranous glomerulonephritis	0.000108	0.000967	CbGpPWpGaD
Naproxen—SLC22A6—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	0.000107	0.000952	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	9.75e-05	0.000869	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—LRP2—membranous glomerulonephritis	9.66e-05	0.000862	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—RHOA—membranous glomerulonephritis	9.53e-05	0.000849	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	9.47e-05	0.000844	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—APOE—membranous glomerulonephritis	9.41e-05	0.000839	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—ABCA1—membranous glomerulonephritis	9.4e-05	0.000838	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	9.38e-05	0.000837	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—APOA1—membranous glomerulonephritis	9.3e-05	0.000829	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PLA2G1B—membranous glomerulonephritis	9.3e-05	0.000829	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	9.2e-05	0.00082	CbGpPWpGaD
Naproxen—ALB—Hemostasis—PLG—membranous glomerulonephritis	9.17e-05	0.000818	CbGpPWpGaD
Naproxen—PTGS2—Disease—LRP2—membranous glomerulonephritis	9.16e-05	0.000817	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	9.09e-05	0.000811	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	9.03e-05	0.000805	CbGpPWpGaD
Naproxen—SLCO1A2—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	9e-05	0.000803	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	8.98e-05	0.000801	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—TBXAS1—membranous glomerulonephritis	8.61e-05	0.000767	CbGpPWpGaD
Naproxen—AKR1C3—Disease—RHOA—membranous glomerulonephritis	8.51e-05	0.000758	CbGpPWpGaD
Naproxen—SLC22A6—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	8.46e-05	0.000754	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—C3—membranous glomerulonephritis	8.45e-05	0.000754	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—ABCA1—membranous glomerulonephritis	8.19e-05	0.00073	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	7.94e-05	0.000708	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—APOE—membranous glomerulonephritis	7.87e-05	0.000701	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—APOA1—membranous glomerulonephritis	7.78e-05	0.000693	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—LRP2—membranous glomerulonephritis	7.67e-05	0.000684	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—ABCA1—membranous glomerulonephritis	7.64e-05	0.000681	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PLA2G1B—membranous glomerulonephritis	7.38e-05	0.000658	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—ALB—membranous glomerulonephritis	7.37e-05	0.000657	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	7.35e-05	0.000655	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	7.3e-05	0.000651	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	7.22e-05	0.000643	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	7.2e-05	0.000642	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—TBXAS1—membranous glomerulonephritis	7e-05	0.000624	CbGpPWpGaD
Naproxen—ALB—Metabolism—TBXAS1—membranous glomerulonephritis	6.96e-05	0.000621	CbGpPWpGaD
Naproxen—ALB—Hemostasis—APOA1—membranous glomerulonephritis	6.41e-05	0.000572	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	6.28e-05	0.00056	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—LRP2—membranous glomerulonephritis	6.24e-05	0.000557	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—ABCA1—membranous glomerulonephritis	6.23e-05	0.000555	CbGpPWpGaD
Naproxen—ALB—Metabolism—LRP2—membranous glomerulonephritis	6.21e-05	0.000553	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—APOE—membranous glomerulonephritis	6.18e-05	0.000551	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—APOA1—membranous glomerulonephritis	6.11e-05	0.000545	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PLA2G1B—membranous glomerulonephritis	6.01e-05	0.000536	CbGpPWpGaD
Naproxen—ALB—Metabolism—PLA2G1B—membranous glomerulonephritis	5.97e-05	0.000533	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—RHOA—membranous glomerulonephritis	5.96e-05	0.000531	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	5.94e-05	0.00053	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	5.91e-05	0.000527	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	5.87e-05	0.000524	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	5.84e-05	0.000521	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	5.72e-05	0.00051	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—TBXAS1—membranous glomerulonephritis	5.7e-05	0.000508	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	5.55e-05	0.000495	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—APOE—membranous glomerulonephritis	5.38e-05	0.00048	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—APOA1—membranous glomerulonephritis	5.32e-05	0.000475	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—LRP2—membranous glomerulonephritis	5.08e-05	0.000453	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—APOE—membranous glomerulonephritis	5.02e-05	0.000448	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—APOA1—membranous glomerulonephritis	4.97e-05	0.000443	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ABCA1—membranous glomerulonephritis	4.94e-05	0.000441	CbGpPWpGaD
Naproxen—ALB—Hemostasis—RHOA—membranous glomerulonephritis	4.91e-05	0.000438	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PLA2G1B—membranous glomerulonephritis	4.89e-05	0.000436	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—TBXAS1—membranous glomerulonephritis	4.87e-05	0.000434	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—ALB—membranous glomerulonephritis	4.84e-05	0.000432	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	4.83e-05	0.000431	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	4.78e-05	0.000426	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—MMP9—membranous glomerulonephritis	4.73e-05	0.000422	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	4.65e-05	0.000415	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—LRP2—membranous glomerulonephritis	4.34e-05	0.000387	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—ALB—membranous glomerulonephritis	4.22e-05	0.000376	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PLA2G1B—membranous glomerulonephritis	4.18e-05	0.000373	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	4.13e-05	0.000368	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—APOE—membranous glomerulonephritis	4.1e-05	0.000365	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	4.08e-05	0.000364	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—APOA1—membranous glomerulonephritis	4.05e-05	0.000361	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ABCA1—membranous glomerulonephritis	4.02e-05	0.000359	CbGpPWpGaD
Naproxen—ALB—Metabolism—ABCA1—membranous glomerulonephritis	4e-05	0.000357	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—ALB—membranous glomerulonephritis	3.94e-05	0.000351	CbGpPWpGaD
Naproxen—PTGS2—Disease—APOE—membranous glomerulonephritis	3.88e-05	0.000346	CbGpPWpGaD
Naproxen—PTGS2—Disease—APOA1—membranous glomerulonephritis	3.84e-05	0.000342	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	3.79e-05	0.000338	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ABCA1—membranous glomerulonephritis	3.27e-05	0.000292	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—APOE—membranous glomerulonephritis	3.25e-05	0.00029	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	3.24e-05	0.000288	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—APOA1—membranous glomerulonephritis	3.21e-05	0.000287	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—ALB—membranous glomerulonephritis	3.21e-05	0.000286	CbGpPWpGaD
Naproxen—PTGS2—Disease—RHOA—membranous glomerulonephritis	2.94e-05	0.000262	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ABCA1—membranous glomerulonephritis	2.8e-05	0.000249	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—APOE—membranous glomerulonephritis	2.65e-05	0.000236	CbGpPWpGaD
Naproxen—ALB—Metabolism—APOE—membranous glomerulonephritis	2.63e-05	0.000235	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—APOA1—membranous glomerulonephritis	2.62e-05	0.000233	CbGpPWpGaD
Naproxen—ALB—Metabolism—APOA1—membranous glomerulonephritis	2.6e-05	0.000232	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ALB—membranous glomerulonephritis	2.55e-05	0.000227	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—APOE—membranous glomerulonephritis	2.15e-05	0.000192	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—APOA1—membranous glomerulonephritis	2.13e-05	0.00019	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ALB—membranous glomerulonephritis	2.07e-05	0.000185	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—APOE—membranous glomerulonephritis	1.84e-05	0.000164	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—APOA1—membranous glomerulonephritis	1.82e-05	0.000162	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ALB—membranous glomerulonephritis	1.69e-05	0.00015	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ALB—membranous glomerulonephritis	1.44e-05	0.000128	CbGpPWpGaD
